US futures steady as Alphabet spending, Qualcomm outlook rattle tech
US stock index futures were largely unchanged on Thursday as investors digested mixed signals from corporate earnings, rising artificial intelligence spending plans, and
Economy
Economy
This historical pattern shows how low XRP price could go before rebounding
XRP, the utility token in the open-source, permissionless and decentralised technology XRP Ledger (XRPL), has been on a rollercoaster ride in recent months. After
Economy
Regulatory pressures drive demand for secure XMR to USDT Exchange in 2026
The opening weeks of 2026 have shown a period of intense downward momentum for the digital asset market. Geopolitical tensions in the Middle
Economy
Plug Power stock: technical analysis points to a big dive soon
Plug Power stock price remained in a bear market after plunging from a high of $4.58 in October last year to the current
Economy
Playnance goes public after years of building scaled Web2-to-Web3 gaming infra
Playnance has made its first public announcement, introducing itself as a Web3 infrastructure and consumer platform that has been operating a live ecosystem
Economy
Coinbase stock price analysis: will it crash to $125 after earnings?
Coinbase stock price continued its strong downward trend this year, reaching its lowest level since April last year. COIN dropped to $166, down
Economy
BoE holds rate but narrow vote fuels expectations of spring rate cut
The Bank of England opted to keep its benchmark interest rate at 3.75% on Thursday, meeting market forecasts but revealing a deeply divided
Economy
ECB holds rates steady as global risks overshadow easing inflation
The European Central Bank (ECB) kept interest rates unchanged on Thursday, signalling confidence that inflation will stabilise over time even as recent data
Economy
Snap stock price loses key support as North America user growth fades
The Snap stock price crashed to a record low and flipped a crucial support level for the first time ever. It dropped to
Economy
Eli Lilly beats earnings, lifts outlook on booming Zepbound and Mounjaro sales
Eli Lilly reported stronger-than-expected fourth-quarter earnings and issued robust guidance for the coming year, as soaring demand for its GLP-1 drugs reaffirmed its